Cargando…

Construction of a novel mRNAsi-related risk model for predicting prognosis and immunotherapy response in osteosarcoma

BACKGROUND: Targeting cancer stem cells (CSC) may represent a future therapeutic direction for osteosarcoma (OS), which mainly relies on the identification of CSC markers. This study aimed to classify OS based on messenger ribonucleic acid (mRNA) stemness indices (mRNAsi) and construct a mRNAsi-rela...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhe, Jin, Chi, Lu, Xinchang, Zhang, Yan, Zhang, Yi, Wen, Jia, Liu, Yongkui, Liu, Xiaoting, Li, Jiazhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929782/ https://www.ncbi.nlm.nih.gov/pubmed/36819514 http://dx.doi.org/10.21037/atm-22-6011

Ejemplares similares

Prognostic Value of mRNAsi/Corrected mRNAsi Calculated by the One-Class Logistic Regression Machine-Learning Algorithm in Glioblastoma Within Multiple Datasets
por: Zhang, Mingwei, et al.
Publicado: (2021)

Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma
por: Huang, Haifu, et al.
Publicado: (2023)

Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer
por: Zhao, Xugui, et al.
Publicado: (2022)

mRNAsi Index: Machine Learning in Mining Lung Adenocarcinoma Stem Cell Biomarkers
por: Zhang, Yitong, et al.
Publicado: (2020)

mRNAsi-related genes can effectively distinguish hepatocellular carcinoma into new molecular subtypes
por: Wang, Canbiao, et al.
Publicado: (2022)

Identification, and Experimental and Bioinformatics Validation of an Immune-Related Prognosis Gene Signature for Low-Grade Glioma Based on mRNAsi
por: Wang, Yuan, et al.
Publicado: (2023)

Identification of Prognostic Markers and Potential Therapeutic Targets in Gastric Adenocarcinoma by Machine Learning Based on mRNAsi Index
por: Guo, Si Hong, et al.
Publicado: (2022)

An N6-methyladenosine regulation- and mRNAsi-related prognostic index reveals the distinct immune microenvironment and immunotherapy responses in lower-grade glioma
por: Tang, Guihua, et al.
Publicado: (2023)

Analyzing mRNAsi-Related Genes Identifies Novel Prognostic Markers and Potential Drug Combination for Patients with Basal Breast Cancer
por: Huang, Kai, et al.
Publicado: (2021)

Identifying 8-mRNAsi Based Signature for Predicting Survival in Patients With Head and Neck Squamous Cell Carcinoma via Machine Learning
por: Tian, Yuxi, et al.
Publicado: (2020)

Developing a 5-Gene Signature Related to Pyroptosis for Osteosarcoma Patients
por: Li, Zhe, et al.
Publicado: (2022)

mRNAsi-related metabolic risk score model identifies poor prognosis, immunoevasive contexture, and low chemotherapy response in colorectal cancer patients through machine learning
por: Weng, Meilin, et al.
Publicado: (2022)

MACC1 Contributes to the Development of Osteosarcoma Through Regulation of the HGF/c-Met Pathway and Microtubule Stability
por: Wen, Jia, et al.
Publicado: (2020)

The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis
por: Zhang, Bin, et al.
Publicado: (2020)

Construction and Validation of a Macrophage-Associated Risk Model for Predicting the Prognosis of Osteosarcoma
por: Xiao, Kang-Wen, et al.
Publicado: (2021)

A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes
por: Tang, Haijun, et al.
Publicado: (2023)

Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinoma
por: Shen, Hong-Yu, et al.
Publicado: (2023)

Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma
por: Zong, Yuan, et al.
Publicado: (2023)

Prediction of Prognosis and Immunotherapy of Osteosarcoma Based on Necroptosis-Related lncRNAs
por: Wang, Guowei, et al.
Publicado: (2022)

Decreased WWOX expression promotes angiogenesis in osteosarcoma
por: Wen, Jia, et al.
Publicado: (2017)

Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma
por: Yang, Jinpo, et al.
Publicado: (2022)

A ubiquitin-related gene signature for predicting prognosis and constructing molecular subtypes in osteosarcoma
por: Wei, Nan, et al.
Publicado: (2022)

Novel Immunotherapies for Osteosarcoma
por: Lu, Yubao, et al.
Publicado: (2022)

Subtype Classification and Prognosis Signature Construction of Osteosarcoma Based on Cellular Senescence-Related Genes
por: Wang, Hanyu, et al.
Publicado: (2022)

Construction and validation of an oxidative-stress-related risk model for predicting the prognosis of osteosarcoma
por: Wang, Hanning, et al.
Publicado: (2023)

Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients
por: Li, Long-Qing, et al.
Publicado: (2020)

PROSER2 is a poor prognostic biomarker for patients with osteosarcoma and promotes proliferation, migration and invasion of osteosarcoma cells
por: Li, Zhengjiang, et al.
Publicado: (2022)

Comprehensive multi-omics analysis reveals m7G-related signature for evaluating prognosis and immunotherapy efficacy in osteosarcoma
por: Zhang, Yiming, et al.
Publicado: (2023)

Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality
por: Yu, Lei, et al.
Publicado: (2022)

Epithelial to Mesenchymal Transition Relevant Subtypes with Distinct Prognosis and Responses to Chemo- or Immunotherapies in Osteosarcoma
por: Zhou, Yang, et al.
Publicado: (2022)

Construction of Molecular Subtype and Prognosis Prediction Model of Osteosarcoma Based on Aging-Related Genes
por: Dong, Chunli, et al.
Publicado: (2022)

Characterization of osteosarcoma subtypes mediated by macrophage-related genes and creation and validation of a risk score system to quantitatively assess the prognosis of osteosarcoma and reflect the tumor microenvironment
por: Liu, Zhe, et al.
Publicado: (2022)

Construction and validation of a novel angiogenesis pattern to predict prognosis and immunotherapy efficacy in colorectal cancer
por: Li, Zhiyong, et al.
Publicado: (2023)

Machine learning-based construction of immunogenic cell death-related score for improving prognosis and response to immunotherapy in melanoma
por: Li, Guoyin, et al.
Publicado: (2023)

Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma
por: Li, Jianhao, et al.
Publicado: (2020)

Construction of a cuproptosis‐related lncRNA signature for predicting prognosis and immune landscape in osteosarcoma patients
por: Ni, Shumin, et al.
Publicado: (2022)

A Recurrent Synovial Osteochondromatosis of the Knee: A Case Report
por: Manandhar, Sripur, et al.
Publicado: (2021)

Bioinformatics Analysis Reveals an Association between Autophagy, Prognosis, Tumor Microenvironment, and Immunotherapy in Osteosarcoma
por: Ma, Yibo, et al.
Publicado: (2022)

Machine-Learning-Based m5C Score for the Prognosis Diagnosis of Osteosarcoma
por: Zhang, Haijie, et al.
Publicado: (2021)

The Prognostic Model Established by the Differential Expression Genes Based on CD8(+) T Cells to Evaluate the Prognosis and the Response to Immunotherapy in Osteosarcoma
por: Chen, Yu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v84ub5org0a4738st2c2uq0r93